Health Care - Spark Newswire

1 minute read

Novavax’s COVID-19 Vaccine Candidate Showed Immune Response, Protection Against Variants

Today, 7:37 AM

Novavax Inc (NASDAQ:NVAX) announced preclinical and clinical data on its recombinant protein COVID-19 vaccine candidate, NVX-CoV2373, directed against the SARS-CoV-2 Beta…

NVAX

3 minute read

The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs

By Shanthi Rexaline

Today, 7:37 AM

Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves.

ALXN

1 minute read

Moderna Says No Link Between COVID-19 Jab And Heart Inflammation

By Vandana Singh

Today, 7:37 AM

Moderna Inc (NASDAQ:MRNA) says there is no “causal association” between its COVID-19 vaccine and cases of myocarditis or pericarditis, based…

BNTX

1 minute read

Peter Thiel-Backed Psychedelic Firm Atai Sets Terms For US IPO, Sees $2.3B Valuation

By Vandana Singh

Today, 7:37 AM

Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, has announced terms for its initial public offering.

ATAI

1 minute read

Zynerba’s Zygel Improves Sleep In Children With Severe Epilepsies

By Vandana Singh

Today, 7:37 AM

Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) presents sleep data from an open-label Phase 2 trial evaluating Zygel for developmental & epileptic encephalopathies (DEE)…

ZYNE